Qizheng Tibetan Medicine announced that Qizheng Group, the controlling shareholder of the company, holds 365 million shares, accounting for 63.72% of the company's total share capital. It recently pledged 6.8 million shares, accounting for 1.87% of its shares and 1.19% of the company's total share capital. The pledge start date is September 16, 2026, and the expiration date is February 24, 2028. The pledge holder is Huaxia Bank Lanzhou Branch. The purpose of the pledge is production and operation. After this pledge, Qizheng Group pledged a total of 59.3 million shares, accounting for 16.27% of its shares and 10.36% of the company's total share capital. There is no risk of liquidation or forced transfer.

Qizheng Tibetan Medicine announced that Qizheng Group, the controlling shareholder of the company, holds 365 million shares, accounting for 63.72% of the company's total share capital. It recently pledged 6.8 million shares, accounting for 1.87% of its shares and 1.19% of the company's total share capital. The pledge start date is September 16, 2026, and the expiration date is February 24, 2028. The pledge holder is Huaxia Bank Lanzhou Branch. The purpose of the pledge is production and operation. After this pledge, Qizheng Group pledged a total of 59.3 million shares, accounting for 16.27% of its shares and 10.36% of the company's total share capital. There is no risk of liquidation or forced transfer.